CryoPort Holds 2025 Annual Stockholders Meeting

The latest update is out from CryoPort ( (CYRX) ).

On June 6, 2025, Cryoport, Inc. held its 2025 Annual Meeting of Stockholders, where several key proposals were voted on. The election of directors resulted in the appointment of six individuals to serve until the 2026 Annual Meeting. Additionally, the appointment of Deloitte and Touche LLP as the independent registered public accounting firm was ratified. Stockholders also approved the compensation of the company’s named executive officers and decided to hold an advisory vote on this compensation annually.

The most recent analyst rating on (CYRX) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on CryoPort stock, see the CYRX Stock Forecast page.

Spark’s Take on CYRX Stock

According to Spark, TipRanks’ AI Analyst, CYRX is a Neutral.

CryoPort’s stock score is primarily driven by the positive outlook and strategic partnerships outlined in the earnings call. However, significant financial and valuation challenges, along with mixed technical indicators, temper the overall assessment.

To see Spark’s full report on CYRX stock, click here.

More about CryoPort

Cryoport, Inc. operates in the life sciences industry, providing temperature-controlled logistics solutions for the biopharmaceutical sector. The company focuses on supporting the global biopharma industry with its advanced supply chain solutions, ensuring the safe transport of critical and temperature-sensitive materials.

Average Trading Volume: 511,385

Technical Sentiment Signal: Sell

Current Market Cap: $351M

See more data about CYRX stock on TipRanks’ Stock Analysis page.